MedTrace Logo

Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population

NCT04500912 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 736

Last updated 2023-09-15

No results posted yet for this study

Summary

The study compares the outcome of the ultrathin stent strut Supraflex Cruz stent to the thin stent strut Ultimaster Tansei stent in a PCI population at high risk for bleeding (HBR).

Conditions

  • Cardiac Disease
  • PCI
  • High Bleeding Risk

Interventions

DEVICE

Supraflex Cruz 60 Micron

percutaneous coronary intervention

DEVICE

Ultimaster Tansei 80 Micron

percutaneous coronary intervention

Sponsors & Collaborators

  • Sahajanand Medical Technologies Limited

    collaborator INDUSTRY

  • Pieter C.Smits

    lead OTHER

Principal Investigators

  • Pieter Smits, MD, PhD · Research Maatschap Cardiologen Rotterdam Zuid

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-14
Primary Completion
2023-09-01
Completion
2023-09-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04500912 on ClinicalTrials.gov